These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 30832601

  • 21. MiR-100-3p and miR-877-3p regulate overproduction of IL-8 and IL-1β in mesangial cells activated by secretory IgA from IgA nephropathy patients.
    Liang Y, Zhao G, Tang L, Zhang J, Li T, Liu Z.
    Exp Cell Res; 2016 Oct 01; 347(2):312-21. PubMed ID: 27542871
    [Abstract] [Full Text] [Related]

  • 22. Analysis of the differential urinary protein profile in IgA nephropathy patients of Uygur ethnicity.
    Guo Z, Wang Z, Lu C, Yang S, Sun H, Reziw, Guo Y, Sun W, Yue H.
    BMC Nephrol; 2018 Dec 14; 19(1):358. PubMed ID: 30547763
    [Abstract] [Full Text] [Related]

  • 23. Urinary Erythrocyte-Derived miRNAs: Emerging Role in IgA Nephropathy.
    Duan ZY, Cai GY, Li JJ, Bu R, Chen XM.
    Kidney Blood Press Res; 2017 Dec 14; 42(4):738-748. PubMed ID: 29050002
    [Abstract] [Full Text] [Related]

  • 24. Urinary Biomarkers in the Prediction of Prognosis and Treatment Response in IgA Nephropathy.
    Neuhaus J, Bauer F, Fitzner C, Hilgers RD, Seibert F, Babel N, Doevelaar A, Eitner F, Floege J, Rauen T, Westhoff TH.
    Kidney Blood Press Res; 2018 Dec 14; 43(5):1563-1572. PubMed ID: 30347407
    [Abstract] [Full Text] [Related]

  • 25. MicroRNA-155-induced T lymphocyte subgroup drifting in IgA nephropathy.
    Yang L, Zhang X, Peng W, Wei M, Qin W.
    Int Urol Nephrol; 2017 Feb 14; 49(2):353-361. PubMed ID: 27796698
    [Abstract] [Full Text] [Related]

  • 26. Identification of a uromodulin fragment for diagnosis of IgA nephropathy.
    Wu J, Wang N, Wang J, Xie Y, Li Y, Liang T, Wang J, Yin Z, He K, Chen X.
    Rapid Commun Mass Spectrom; 2010 Jul 30; 24(14):1971-8. PubMed ID: 20552702
    [Abstract] [Full Text] [Related]

  • 27. Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy.
    Yoon SY, Kim JS, Jung SW, Kim YG, Hwang HS, Moon JY, Lee SH, Seo JW, Seok J, Tae D, Jeong K.
    Sci Rep; 2023 Oct 11; 13(1):17201. PubMed ID: 37821628
    [Abstract] [Full Text] [Related]

  • 28. Urinary miR-185-5p is a biomarker of renal tubulointerstitial fibrosis in IgA nephropathy.
    Duan ZY, Bu R, Liang S, Chen XZ, Zhang C, Zhang QY, Li JJ, Chen XM, Cai GY.
    Front Immunol; 2024 Oct 11; 15():1326026. PubMed ID: 38426107
    [Abstract] [Full Text] [Related]

  • 29. Noninvasive Urinary Monitoring of Progression in IgA Nephropathy.
    Yang JYC, Sarwal RD, Fervenza FC, Sarwal MM, Lafayette RA.
    Int J Mol Sci; 2019 Sep 10; 20(18):. PubMed ID: 31510053
    [Abstract] [Full Text] [Related]

  • 30. Decreased Expression of Urinary Mammalian Target of Rapamycin mRNA Is Related to Chronic Renal Fibrosis in IgAN.
    Cao Y, Wang Y, Liu Y, Zhu X, Zhang G, Wang S, Chen X, Liu D, Fu C.
    Dis Markers; 2019 Sep 10; 2019():2424751. PubMed ID: 31485275
    [Abstract] [Full Text] [Related]

  • 31. MicroRNAs in IgA nephropathy.
    Yao X, Zhai Y, An H, Gao J, Chen Y, Zhang W, Zhao Z.
    Ren Fail; 2021 Dec 10; 43(1):1298-1310. PubMed ID: 34547971
    [Abstract] [Full Text] [Related]

  • 32. Urinary exosomal mRNAs as biomarkers for predicting the therapeutic effect of renin-angiotensin system inhibitors in IgA nephropathy patients.
    Zhao B, Wang M, Cong Y, Song A, Lu J, Xie K, Dai H, Gu L.
    Clin Chim Acta; 2024 Jul 15; 561():119750. PubMed ID: 38885756
    [Abstract] [Full Text] [Related]

  • 33. Exosomal miR-4639 and miR-210 in Plasma and Urine as Biomarkers in IgA Nephropathy.
    Zhao S, Sun Y, Mao Q, Zhou C, Chen Y, Xue D.
    Nephron; 2022 Jul 15; 146(6):539-552. PubMed ID: 35381590
    [Abstract] [Full Text] [Related]

  • 34. Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
    Suzuki H, Allegri L, Suzuki Y, Hall S, Moldoveanu Z, Wyatt RJ, Novak J, Julian BA.
    Dis Markers; 2016 Jul 15; 2016():7806438. PubMed ID: 27647947
    [Abstract] [Full Text] [Related]

  • 35. A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity.
    Han QX, Wang Y, Zhu HY, Zhang D, Gao J, Liu ZS, Cai GY, Chen XM.
    Chin Med J (Engl); 2019 Mar 20; 132(6):647-652. PubMed ID: 30855344
    [Abstract] [Full Text] [Related]

  • 36. Urinary Exosomes and Exosomal CCL2 mRNA as Biomarkers of Active Histologic Injury in IgA Nephropathy.
    Feng Y, Lv LL, Wu WJ, Li ZL, Chen J, Ni HF, Zhou LT, Tang TT, Wang FM, Wang B, Chen PS, Crowley SD, Liu BC.
    Am J Pathol; 2018 Nov 20; 188(11):2542-2552. PubMed ID: 30142333
    [Abstract] [Full Text] [Related]

  • 37. Expressions of mRNA for innate immunity-associated functional molecules in urinary sediment in immunoglobulin A nephropathy.
    Tsuruga K, Aizawa T, Watanabe S, Tsugawa K, Yoshida H, Imaizumi T, Ito E, Tanaka H.
    Nephrology (Carlton); 2015 Dec 20; 20(12):916-21. PubMed ID: 26058859
    [Abstract] [Full Text] [Related]

  • 38. Urinary CXCL1: a novel predictor of IgA nephropathy progression.
    Zhao Y, Zhu L, Zhou T, Zhang Q, Shi S, Liu L, Lv J, Zhang H.
    PLoS One; 2015 Dec 20; 10(3):e0119033. PubMed ID: 25816025
    [Abstract] [Full Text] [Related]

  • 39. LG3 fragment of endorepellin is a possible biomarker of severity in IgA nephropathy.
    Surin B, Sachon E, Rougier JP, Steverlynck C, Garreau C, Lelongt B, Ronco P, Piedagnel R.
    Proteomics; 2013 Jan 20; 13(1):142-52. PubMed ID: 23161552
    [Abstract] [Full Text] [Related]

  • 40. Mapping novel immunogenic epitopes in IgA nephropathy.
    Woo SH, Sigdel TK, Dinh VT, Vu MT, Sarwal MM, Lafayette RA.
    Clin J Am Soc Nephrol; 2015 Mar 06; 10(3):372-81. PubMed ID: 25542908
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.